Golden Developin Stock Price, News & Analysis
Company Description
Golden Developin (OTC Link: DVLP) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $141.3K.
DVLP stock has gained 0.0% over the past year. Shares last traded at $0.0000.
On a trailing twelve-month basis, Golden Developin reported net income of -$1.4M and diluted earnings per share of $0.00.
This page provides a comprehensive overview of DVLP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Golden Developin (DVLP) stock last traded at $0.0000. At a market capitalization of $141.3K, DVLP is classified as a micro-cap stock with approximately 1.4B shares outstanding.
Latest News
Golden Developin has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition. View all DVLP news →
SEC Filings
Financial Highlights
operating income reached -$646K, and net income was -$1.4M. Diluted earnings per share stood at $0.00. The company generated $183K in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Golden Developin (DVLP) currently stands at 29 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Golden Developin (DVLP) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
DVLP Company Profile & Sector Positioning
Golden Developin (DVLP) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing DVLP often look at related companies in the same sector, including Centr Brands (CNTRF), Pineapple Express Cannabis Co (PNXP), Viaderma (VDRM), Xebra Brands (XBRAF), and Cryomass Technologies Inc (CRYM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DVLP's relative position within its industry.